Nature's Miracle ("NMHI") Opened Office in Tokyo for the Tokenization Opportunities in Japan

Rhea-AI Summary

Nature's Miracle (NASDAQ: NMHI) opened a representative office in Tokyo's Toranomon Central Business District on October 27, 2025 and appointed Yoseuke Morimoto as local representative director.

The company said the Tokyo presence positions it to pursue tokenization opportunities in carbon credits, mining and real-world assets (RWA). The release notes Japan classifies cryptocurrencies as legal assets under the Payment Services Act and requires exchanges to register with the Financial Services Agency (FSA), which the company cites as supportive regulatory context.

The company expects the office to provide access to institutional and sophisticated investors in Asia while developing RWA tokenization products.

TOKYO, Oct. 27, 2025 /PRNewswire/ -- On October 27, Nature's Miracle Holding Inc. (NMHI) ("Nature's Miracle" or the "Company") opened an office in the Toranomon Central Business District of Tokyo and the appointment of a local representative director Yoseuke Morimoto. Tokyo is an international finance hub and Japan has a robust regulatory framework for cryptocurrencies, classifying them as legal assets under the Payment Services Act and requiring crypto exchanges to register with the Financial Services Agency (FSA). By opening a representative office in Tokyo, Nature's Miracle is well positioned to develop tokenization opportunities in carbon credit, mining and real world assets. 

Mr. Tie "James" Li, Chairman and CEO of Nature's Miracle Holding Inc said: "We are delighted to welcome Mr. Morimoto to the Nature's Miracle team, given his connection and experience in Japan. We view our presence in Tokyo give us the access to the most sophisticated investors in Asia and to develop the RWA Tokenization products."

About Nature's Miracle Holding Inc.

N Nature's Miracle (www.Nature-Miracle.com) is a growing agriculture technology company providing products and services to growers in the Controlled Environment Agriculture ("CEA") industry in the U.S. The Company's Common Stock trades on the OTCQB market ("OTCQB") under the symbol "NMHI".

Forward-Looking Statements

The information in this press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast," "intends," "may," "will," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature's Miracle's joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature's Miracle's strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature's Miracle's ability to develop and launch new products and services; Nature's Miracle's ability to successfully and efficiently integrate future expansion plans and opportunities; Nature's Miracle's ability to grow its business in a cost-effective manner; Nature's Miracle's product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature's Miracle's business model; developments and projections relating to Nature's Miracle's competitors and industry; and Nature's Miracle's approach and goals with respect to technology.

These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company's shares on the OTC; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature's Miracle's operates; the risk that Nature's Miracle's and its current and future collaborators are unable to successfully develop and commercialize Nature's Miracle's products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature's Miracle's is unable to secure or protect its intellectual property; the possibility that Nature's Miracle's may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature's Miracle's filings from time to time with the SEC.

For more information, please contact:

Nature's Miracle Holding, Inc.
George Yutuc, CFO COO
george.yutuc@nature-miracle.com  or

info@nature-miracle.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/natures-miracle-nmhi-opened-office-in-tokyo-for-the-tokenization-opportunities-in-japan-302595357.html

SOURCE Nature's Miracle Holding Inc.

FAQ

When did Nature's Miracle (NMHI) open its Tokyo office and who was appointed?

Nature's Miracle opened a Tokyo office on October 27, 2025 and appointed Yoseuke Morimoto as representative director.

What tokenization opportunities is NMHI pursuing from its Tokyo office?

The company said it will pursue tokenization in carbon credits, mining and real-world assets (RWA).

How does Japan's regulatory framework affect NMHI's Tokyo strategy (NMHI)?

Japan classifies cryptocurrencies as legal assets under the Payment Services Act and requires exchanges to register with the Financial Services Agency (FSA), which the company says provides a supportive regulatory context.

Where is Nature's Miracle's Tokyo office located and why is the location significant?

The office is in Tokyo's Toranomon Central Business District, a major international finance hub the company says offers access to sophisticated Asian investors.

Will the Tokyo office immediately change NMHI's product offerings or stock guidance?

The announcement describes strategic positioning for tokenization but does not provide any financial guidance or immediate product launch dates.

How can investors follow updates about NMHI's tokenization projects in Japan?

Investors should monitor the company's investor communications and filings for formal project updates, timelines, and material financial disclosures.